Effectiveness of Bee Venom Injection for Parkinson’s Disease: A Systematic Review
Parkinson’s disease (PD) is the second most common neurodegenerative disorder worldwide, affecting over 8.5 million people as of 2019. While standard pharmacological treatments help alleviate symptoms, their long-term use can lead to side effects such as dyskinesia. Bee venom acupuncture (BVA) invol...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/17/4/204 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849714060186091520 |
|---|---|
| author | Hyein Jeong Kyeong Han Kim Seong-gyu Ko |
| author_facet | Hyein Jeong Kyeong Han Kim Seong-gyu Ko |
| author_sort | Hyein Jeong |
| collection | DOAJ |
| description | Parkinson’s disease (PD) is the second most common neurodegenerative disorder worldwide, affecting over 8.5 million people as of 2019. While standard pharmacological treatments help alleviate symptoms, their long-term use can lead to side effects such as dyskinesia. Bee venom acupuncture (BVA) involves the use of a natural toxin derived from bees that can be used for pain relief and treating neurological disorders. This study aimed to review the efficacy and safety of BVA for the treatment of PD. This review protocol was prospectively registered with PROSPERO (CRD420251000577). We searched eight databases in February 2025 and selected 12 studies involving 215 PD patients treated with BVA. Idiopathic Parkinson’s disease (IPD) is the most common diagnosis. The concentration and dosage per session ranged from 0.03 to 0.1 mg/mL and from 0.1 to 1.0 mL, respectively. Twenty-four different outcome measures were used, with the Unified PD Rating Scale employed in 91.7% of the studies. All studies reported improvements in outcomes. Mild adverse effects such as swelling and itching were noted in four studies (33.3%); however, no severe reactions such as anaphylactic shock occurred. These findings suggest that BVA has the potential for broader clinical applications in the treatment of PD. |
| format | Article |
| id | doaj-art-e54a72478c2748a4a59414e87d16272e |
| institution | DOAJ |
| issn | 2072-6651 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Toxins |
| spelling | doaj-art-e54a72478c2748a4a59414e87d16272e2025-08-20T03:13:48ZengMDPI AGToxins2072-66512025-04-0117420410.3390/toxins17040204Effectiveness of Bee Venom Injection for Parkinson’s Disease: A Systematic ReviewHyein Jeong0Kyeong Han Kim1Seong-gyu Ko2Department of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02446, Republic of KoreaDepartment of Preventive Medicine, College of Korean Medicine, Woosuk University, Jeonju 55338, Republic of KoreaDepartment of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02446, Republic of KoreaParkinson’s disease (PD) is the second most common neurodegenerative disorder worldwide, affecting over 8.5 million people as of 2019. While standard pharmacological treatments help alleviate symptoms, their long-term use can lead to side effects such as dyskinesia. Bee venom acupuncture (BVA) involves the use of a natural toxin derived from bees that can be used for pain relief and treating neurological disorders. This study aimed to review the efficacy and safety of BVA for the treatment of PD. This review protocol was prospectively registered with PROSPERO (CRD420251000577). We searched eight databases in February 2025 and selected 12 studies involving 215 PD patients treated with BVA. Idiopathic Parkinson’s disease (IPD) is the most common diagnosis. The concentration and dosage per session ranged from 0.03 to 0.1 mg/mL and from 0.1 to 1.0 mL, respectively. Twenty-four different outcome measures were used, with the Unified PD Rating Scale employed in 91.7% of the studies. All studies reported improvements in outcomes. Mild adverse effects such as swelling and itching were noted in four studies (33.3%); however, no severe reactions such as anaphylactic shock occurred. These findings suggest that BVA has the potential for broader clinical applications in the treatment of PD.https://www.mdpi.com/2072-6651/17/4/204Parkinson’s diseasebee venombee venom acupuncturesystematic review |
| spellingShingle | Hyein Jeong Kyeong Han Kim Seong-gyu Ko Effectiveness of Bee Venom Injection for Parkinson’s Disease: A Systematic Review Toxins Parkinson’s disease bee venom bee venom acupuncture systematic review |
| title | Effectiveness of Bee Venom Injection for Parkinson’s Disease: A Systematic Review |
| title_full | Effectiveness of Bee Venom Injection for Parkinson’s Disease: A Systematic Review |
| title_fullStr | Effectiveness of Bee Venom Injection for Parkinson’s Disease: A Systematic Review |
| title_full_unstemmed | Effectiveness of Bee Venom Injection for Parkinson’s Disease: A Systematic Review |
| title_short | Effectiveness of Bee Venom Injection for Parkinson’s Disease: A Systematic Review |
| title_sort | effectiveness of bee venom injection for parkinson s disease a systematic review |
| topic | Parkinson’s disease bee venom bee venom acupuncture systematic review |
| url | https://www.mdpi.com/2072-6651/17/4/204 |
| work_keys_str_mv | AT hyeinjeong effectivenessofbeevenominjectionforparkinsonsdiseaseasystematicreview AT kyeonghankim effectivenessofbeevenominjectionforparkinsonsdiseaseasystematicreview AT seonggyuko effectivenessofbeevenominjectionforparkinsonsdiseaseasystematicreview |